These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7256628)

  • 1. [Immunologic examination of patients with rheumatic heart defects during immunosuppressant therapy].
    Petrova IV
    Ter Arkh; 1981; 53(4):115-7. PubMed ID: 7256628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of immunodepressive cytostatic agents in rheumatology].
    Sigidin IaA; Borisova AM
    Sov Med; 1971 Jul; 34(7):110-5. PubMed ID: 5160313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications for indomethacin rheumatic disease with special reference to its combination with immunosuppressive agents].
    Frankl R
    Arzneimittelforschung; 1971 Nov; 21(11):1870-2. PubMed ID: 5171827
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acid phosphatase of the blood serum in rheumatism].
    Astakhova TA; Denisov LN; Kaĭnova AS; Tolmachev IuP
    Ter Arkh; 1974; 46(11):119-22. PubMed ID: 4439277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of the contractile function of the myocardium of the left and right ventricles in patients with rheumatic heart defects in the process of treatment with corglycon].
    Lisin VV
    Sov Med; 1974 Aug; 0(8):94-7. PubMed ID: 4473835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of treatment of rheumatic patients].
    Siudmak NV; Iatskovets LIa; Nabutovskaia RI; Tolstopiat AN
    Vrach Delo; 1966 Dec; 12():118-9. PubMed ID: 6003502
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of Nerobol in the treatment of patients with rheumatic heart disease and circulatory insufficiency].
    Beĭ PI
    Klin Med (Mosk); 1968 Jun; 46(6):104-6. PubMed ID: 5710561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of the course of rheumatic heart disease in middle-aged and elderly patients].
    Adamova NS; Gebler NI; Gratsianov DA
    Ter Arkh; 1971 Jan; 43(1):40-4. PubMed ID: 5574535
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of therapy on the indicators of hemocoagulation and capillary resistance in patients with rheumatic heart defects].
    Mirzoian SN
    Vopr Revm; 1973; 13(2):47-51. PubMed ID: 4772874
    [No Abstract]   [Full Text] [Related]  

  • 10. [The chronocorrection of disorders in the blood coagulation rhythm with kurantil in patients with decompensated rheumatic heart defects].
    Zaslavskaia RM; Logvinenko SI; Logvinenko AG; Teĭblium MM
    Patol Fiziol Eksp Ter; 1997; (2):23-7. PubMed ID: 9235534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of the efficacy of therapy of patients with relapsing rheumatism, taking into consideration the degree of activity of the disease].
    Mikhnev AL; Karapata AP
    Vopr Revm; 1969; 9(2):28-31. PubMed ID: 5363863
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
    Østensen M; von Esebeck M; Villiger PM
    J Rheumatol; 2007 Jun; 34(6):1266-9. PubMed ID: 17516615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.
    Triantafyllou NI; Grapsa EI; Kararizou E; Psimenou E; Lagguranis A; Dimopoulos A
    Ther Apher Dial; 2009 Jun; 13(3):174-8. PubMed ID: 19527462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of anabolic steroids on the blood coagulation indicators in rheumatic heart disease].
    Furtel' VA
    Vrach Delo; 1981 Oct; (10):31-3. PubMed ID: 7303571
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of the results of current instrumental methods of cardiological examination in the sociomedical expert assessment of patients with rheumatic heart defects].
    Kuz'mishin LE; Komarova LE; Gromova GV
    Ter Arkh; 1994; 66(1):32-4. PubMed ID: 8146790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of heptaminol hydrochloride on the mechanics of systole].
    Rossi P; Mazzuca I; Guido A
    Policlinico Prat; 1966 Jun; 73(24):801-11. PubMed ID: 5940299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of heparin on the activity of the rheumatic process in patients with sluggish rheumocarditis].
    Vitruk SK
    Vrach Delo; 1977 Feb; (2):45-50. PubMed ID: 860458
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy of treatment with the angiotensin-converting enzyme inhibitor ramipril in patients with congestive heart failure of rheumatic etiology].
    Karakin AA; Khrustalev OA; Bol'shakova MA; Forsilov VE
    Ter Arkh; 1996; 68(2):43-6. PubMed ID: 8771657
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapy of rheumatism with latent course in patients with circulatory insufficiency].
    Balakhonova NG; Gogochkina AA
    Vopr Revm; 1966; 6(1):69-72. PubMed ID: 5986401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythropoietic activity of the blood serum in patients with rheumatic heart defects].
    Krylov AA
    Vopr Revm; 1968; 8(2):88-9. PubMed ID: 5742817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.